BREWERS WILL CHANGE THE PSYCHEDELIC LANDSCAPE

MIMOSA is drastically changing the market by offering all-natural psilocybin, grown as mycelia ("roots" of mushrooms) in scalable "brewers." Mimosa's psilocybin brewers can range in size from ~ 2 gallon microbrewers to 50,000 gallon brew vats. The process can be 100% organic (OMRI - Organic Materials Review Institute) compliant, requiring no genetic modifications, no synthetic chemistry and no solvents of any kind. This creates consistent full-spectrum psilocybin, with options for pure psilocybin as well as for measured combinations with baeocystin and other complementary molecules, that is cleaner, less expensive, and superior in quality to traditionally offered entheogenic mushrooms or truffles.

img
Mimosa Brewers

Welcome to Mimosa Therapeutics

The world’s first company to specialize in brewer production of natural psychedelic therapeutics.

We are dedicated to making these available at affordable prices.

Cheaper

More cost-effective than traditional methods of production.

Faster

Using technological advances, our products will yield much quicker.

Cleaner

With more consistency and less chemicals.

Learn More

Most importantly, our process creates a therapeutic with predictably precise quantities of active ingredients. MIMOSA has solved the challenge of how to make medical-grade natural psilocybin. Of great significance is the ability of the brewer to bypass restrictions on shipping psychedelics across state or international boundaries. MIMOSA need only ship Brewers to each new market.

mockup

What is a Brewer?

A brewer is simply a vessel for growing cell cultures. It carefully controls stir rate, temperature, aeration, pH, and other critical variables. They are usually computer controlled.

Commercial Brewers are optimized to produce large quantities of pharmaceutical product at greatly reduced cost.

mockup

MIMOSA is a Public Benefit Corporation.

While we acknowledge the important contributions of the traditional pharmaceutical models, MIMOSA is occupying a different space in the psychedelic industry. We are focused on building a strong brand, customer loyalty, and a level of transparency necessary for participation in the larger university and nonprofit research world.

Our focus is on immediately marketable, natural, non- patented products that don’t require time-consuming and expensive applications to the FDA or other national approval pipelines. Our therapeutics are designed to be widely accessible and affordable, even in the developing world.

Ethics, competence, a gratefulness for the gifts of the natural world, and a sense of responsibility to share these offerings are core to our corporate mission.

Watch Video

Meet Our Team

The Experts Behind Mimosa Therapeutics

Amanda Fielding

Amanda Fielding

Co-founder, Director
James Keim

James Keim

Co-founder, CEO
Felix Blei

Felix Blei

Chief Analytics Officer
Bob Stanley

Bob Stanley

President
Amber Senter

Amber Senter

Chief Operating Officer for North America
John Turner

John Turner

Senior Advisor
Antoni Gandia

Antoni Gandia

Chief Bioreactor Scientist
Alan Rockefeller

Alan Rockefeller

Chief Mycologist

Subscribe Newsletter

Stay informed about our products and plans.